free e-letter

Get all the latest penny share news, advice and market insight absolutely FREE! Just enter your email here:

RED HOT PENNY SHARES

Red Hot Penny Shares

Red Hot Penny Shares hunts down the superstars of tomorrow while they still sell for pennies!

Find out more about Red Hot Penny Shares »

THE BULFORD FILES

The Bulford Files

This high-end advisory concentrates on finding the “hidden value” investments - the safest, cheapest shares in the UK market.

Find out more about The Bulford Files »

Three Beautiful Babies

Date 15/07/2008
Red Hot Penny Shares | By Tom Bulford

Trepidation has taken the place of anticipation.

Every morning, at seven o’clock, I make myself a cup of tea and settle down in front of my PC to read all of the morning’s stock exchange announcements.

This used to be a happy half hour.

I would read of all the progress being made by the UK’s many quoted companies. I would count up those increased dividends. I would purr at higher profits. I would digest the many confident statements of chairmen and chief executives.
Sign up today for our FREE daily newsletter
Enter your email and you will get our FREE newsletter directly to your inbox
It was the intellectual equivalent of three Weetabix, and sent me on my daily rounds with a sense of optimism, happy that the good ship of commerce was chugging its way purposefully through calm seas with my life savings on board.

Now though things are different.

I turn on the PC with a sense of foreboding. I put an extra lump of sugar in my tea to anaesthetize the pain of profit warnings and dividend cuts. And I watch my fortunes sink.

Yesterday though was different. I was prepared for the worst. A week-end spent reading about the wrecks of Fannie Mae and Freddie Mac, of the collapsing housing market, of mounting job losses and credit card debts had steeled me for a miserable morning.


And yet! Not one or two, but three companies reported the happiest of news. News that in different stock market conditions would have propelled their share prices upwards.

These are companies that prove that there is life outside the wretched banking and consumer sectors. There are industries out there that are benefiting from the very trends that threaten recession.

There are companies that are providing a service that is indispensable, whatever the economic climate. And there are companies that are providing such great products that they are displacing existing ones and become a commercial imperative.

Take Hamworthy, for instance. This has been one of the stars of the small cap sector over the last few years, growing its profits at an annual rate of 27%. It has a bright future too, thanks to its expertise in the pumps and systems that handle gas and water on board ships.

Over three quarters of its sales are related to the production and transportation of oil and gas, and it is the latter that really underpins its prospects. The volume of LNG carried by sea is expected to rise by 10% per year until 2015. So no wonder Hamworthy’s chairman reported strong order books and ‘robust long-term growth prospects’ at yesterday’s AGM.
Sign up today for our FREE daily newsletter
Enter your email and you will get our FREE newsletter directly to your inbox
And another…

‘Our core business continues to prosper’ was the phrase used by another chairman, this time David Evans of Immunodiagnostic Systems, as he reported a 23% rise in earnings per share and a 20% hike in the annual dividend.

Since starting out as a distributor of diagnostic products thirty years ago IDS is now a leader in the global In-Vitro Diagnostics industry.

It exports 70% of its products, which are medical diagnostic kits. It has particular expertise in the areas of calcium dysfunction and bone diseases, such as osteoporosis, osteomalacia and Paget’s disease, but its flagship is its kits for the determination of Vitamin D in human serum.

Vitamin D is an important marker in the control and regulation of the body’s calcium reserves and is increasingly being accepted as necessary for the prevention of diseases including breast cancer, prostate cancer, colon cancer, diabetes and heart disease.

Since coming onto AIM in 2004 IDS has grown in exemplary fashion both organically and through acquisition and analysts are forecasting a big jump in earnings this year.

And here’s another…

And the third company to raise my spirits and demonstrate that not everything in the garden is withering away is SDL.

Its shares jumped after Chairman and Chief Executive Mark Lancaster told the market that results for latest six months ‘will be significantly ahead of market expectations’.

Revenues in this period were 37% higher than in 2007, with two thirds of this related to organic growth. So here is a third company that the recession is by-passing, evidence that if the product is good enough it will always succeed.

SDL’s product answers the commercial imperative that multinational organizations must deliver consistent information around the world in a variety of languages. 90% of information that is produced by a global organization is relevant to an international audience and yet, according to SDL, only 10% is delivered in their language.

SDL provides the software and services that can tackle this problem, central to which is software that can automatically translate from one language to another.

The shares of each of these three companies rose yesterday.

Each is a specialist with a worldwide reputation for excellence. In their rush to abandon the stock market, investors must take care not to throw the baby out with the bathwater. These three beautiful babies should each grow into handsome adults in the years ahead.

Regards,

Tom Bulford
for The Penny Sleuth

Sign up today for our FREE daily newsletter
Enter your email and you will get our FREE newsletter directly to your inbox
If you enjoyed this article then sign up for Red Hot Penny Shares. Its aim is simple: to lead you straight to the undiscovered, unloved, under-priced small cap shares destined to become the big boys of the future…
fleetstreetinvest

Your capital is at risk when you invest in shares – you can lose you some or all of your money, so never risk more than you can afford to lose. Figures may refer to the past or be forecasts. Past performance and forecasts are not reliable indicators of future results. The FSA does not regulate certain activities, including the buying and selling of commodities such as gold. If in doubt about the suitability or taxation implications of any investment, seek independent financial advice.